OOIR: Observatory of International Research

Papers

(The TQCC of Blood Cells Molecules and Diseases is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies	32
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)	29
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)	27
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?	26
ABO blood groups, COVID-19 infection and mortality	26
Effectiveness of convalescent plasma in Indian patients with COVID-19	25
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis	20
The potential role of emicizumab prophylaxis in severe von Willebrand disease	19
Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis	18
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?	16
MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies	15
Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study	15
Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis	14
Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model	13
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients	13
Hematologically important mutations: Leukocyte adhesion deficiency (second update)	12
Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders	11
Numbers of long-term hematopoietic stem cells from bone marrow of fanca and fancc knockout mice can be greatly enhanced by their collection and processing in physioxia conditions	11
Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia	10
Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore	10
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria	10
Platelet-derived microvesicles activate human platelets via intracellular calcium mediated reactive oxygen species release	9
High-throughput methods for the analysis of transcription factors and chromatin modifications: Low input, single cell and spatial genomic technologies	9
Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia	9
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India	9

Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature	9
Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease	9
RNF220 promotes the proliferation of leukaemic cells and reduces the degradation of the Cyclin D1 protein through USP22	9
Prognostic factors associated with COVID-19 related severity in sickle cell disease	8
Potential ‘significance’ of monoclonal gammopathy of ‘undetermined significance’ during COVID-19 pandemic	8
Early iron supplementation and iron sufficiency at one month of age in NICU patients at-risk for iron deficiency	7
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort	7
Prognostic significance of CD45 antigen expression in pediatric acute lymphoblastic leukemia	7
Loss of ZNF215 imprinting is associated with poor five-year survival in patients with cytogenetically abnormal-acute myeloid leukemia	7
Aberrant expression of cytokines in polycythemia vera correlate with the risk of thrombosis	7
Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment	6
Development of a Thalassemia International Prognostic Scoring System (TIPSS)	6
Pediatric bone marrow failure: Clinical, hematological and targeted next generation sequencing data	6
A case series highlighting structured hematological, biochemical and molecular approach to clinical oral iron refractoriness in children: A pressing need for a 3-tier system for classification of vari	6
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A−c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations	6
Splicing analysis of SLC40A1 missense variations and contribution to hemochromatosis type 4 phenotypes	6
Daratumumab as a novel treatment option in refractory ITP	6
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency	6
Novel mutations in the EPO-R, VHL and EPAS1 genes in the Congenital Erythrocytosis patients	6
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort	6
Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect	5
VCAM1, HMOX1 and NOS3 differential endothelial expression may impact sickle cell anemia vasculopathy	5
Identification and characterization of novel mutations in Chinese patients with congenital fibrinogen disorders	5
Impact of maternal iron deficiency anemia on fetal iron status and placental iron transporters in human pregnancy	5
γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity	5
Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil	5
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)	5
Good treatment-free survival of monoclonal gammopathy of undetermined significance associated pure red cell aplasia after bortezomib plus dexamethasone	5
Increased proportion and altered properties of intermediate monocytes in the peripheral blood of patients with lower risk Myelodysplastic Syndrome	5
The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients	5
Age-dependent characterization of carotid and cerebral artery geometries in a transgenic mouse model of sickle cell anemia using ultrasound and microcomputed tomography	4
TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia	4
Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content	4
Effects of d-ribose on human erythrocytes: Non-enzymatic glycation of hemoglobin, eryptosis, oxidative stress and energy metabolism	4
Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III	4
New germline GATA1 variant in females with anemia and thrombocytopenia	4
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients	4
Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry	4
JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment	4
Bio-net dataset: AI-based diagnostic solutions using peripheral blood smear images	4
Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients	4
Sickle cell disease mice have cerebral oxidative stress and vascular and white matter abnormalities	4
Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data	4
Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects	4
COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study	4
Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study	4
Hypoferremia of inflammation: Innate host defense against infections	4